Investigational Site Number : 3920005

Hirakata-shi, Osaka 573-1191

0 studies enrolling now · 1 studies all time

What they study most

Non-squamous Non-small Cell Lung Cancer

Studies at this site

• Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA — Stopped early